Multidisciplinary home-based intervention on skin adverse reactions of lung cancer patients with targeted therapy

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000040643

Enrollment

Unknown

Registered

2020-12-05

Start date

2020-12-01

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non small cell lung cancer

Interventions

intervention group:Multidisciplinary home-based intervention

control group:usual care

Eligibility

Sex/Gender

All

Age

45 Years to 82 Years

Inclusion criteria

Inclusion criteria: (1) Pathological diagnosis of NSCLC patients; (2) EGFR-TKIs treatment; (3) home medication; (4) normal cognitive function and communication; (5) informed consent.

Exclusion criteria

Exclusion criteria: (1) Patients do not know their condition; (2) poor physical function, difficult to complete the research; (3) unable to complete the questionnaire independently or with the assistance of investigators.

Design outcomes

Primary

Measure	Time frame
skin adversereactions;	—

Secondary

Measure	Time frame
quality of life;self management efficiency;self perceived burden;self management ability;Karnofsky score;transfer;recurrence;cost;	—

Countries

China

Contacts

Public ContactWang Tao

The College of Nursing and Health of Zhengzhou University

wangtaomary@zzu.edu.cn+86 18838007305

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026